Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
Clinical trial NCT01224652 · UNKNOWN
Trial details
- NCT number
- NCT01224652
- Sponsor
- Korean Cancer Study Group
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.